Page 4 - Heart Failure Program News Today

THURSDAY, July 20, 2023 (HealthDay News) -- Every day, millions of people must take one or more pills to control their blood pressure and reduce their risk for heart attack

THURSDAY, July 20, 2023 (HealthDay News) -- Every day, millions of people must take one or more pills to control their blood pressure and reduce their risk for heart attack

THURSDAY, July 20, 2023 (HealthDay News) -- Every day, millions of people must take one or more pills to control their blood pressure and reduce their risk for heart attack

THURSDAY, July 20, 2023 (HealthDay News) -- Every day, millions of people must take one or more pills to control their blood pressure and reduce their risk for heart attack

THURSDAY, July 20, 2023 (HealthDay News) -- Every day, millions of people must take one or more pills to control their blood pressure and reduce their risk for heart attack

— Dose-Dependent Reductions in Serum Angiotensinogen and 24-hour Ambulatory Blood Pressure Were Sustained for Six Months After Single Doses of Zilebesiran — — Acceptable Safety Profile Supporting Further Development —

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 19, 2023--

His chest hurt warming up for a softball game. A few months later, he was having a heart transplant.

Sandeep Jauhar, MD, PhD, on his career and wrestling with his father's dementia

Healio Rheumatology | For more than a decade, the medical community as a whole, and particularly the field of rheumatology, has been trying to move away from opioids for the management of chronic pain — with varying degrees of success.However, for a growing number of medical experts — in rheumatology and elsewhere — a completely new paradigm and understanding of pain, and its management, is needed.